IL-17A in Human Respiratory Diseases: Innate or Adaptive Immunity? Clinical Implications
Figure 1
Sputum IL-17A mRNA levels in children with CF. Sputum mRNA was extracted from 23 children with CF aged 5–17 years, as described [47]. IL-17A mRNA levels were measured by real-time RT-PCR [44]. Sputum IL-17A mRNA levels in 9 CF children experiencing at least one exacerbation in the past 12 months (1 or more) were compared to those without exacerbation (). * by Mann-Withney test.